Related Experiment Videos
Transformation-associated alterations in interactions between pre-B cells and fibronectin
F M Lemoine1, S Dedhar, G M Lima
1Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, Canada.
Blood
|December 1, 1990
Summary
Normal pre-B cells use fibronectin (FN) to attach to stromal cells, which is crucial for their growth. Leukemic pre-B cells lose this FN binding ability, contributing to their uncontrolled proliferation.
Area of Science:
- Immunology
- Cell Biology
- Hematopoiesis
Background:
- Marrow stromal cells produce growth factors stimulating pre-B cell proliferation.
- Close contact between stromal and pre-B cells enhances the pre-B cell response.
Purpose of the Study:
- To investigate the role of fibronectin (FN) binding in pre-B cell proliferation and stromal cell interaction.
- To understand the mechanisms behind leukemic pre-B cell outgrowth and stromal independence.
Main Methods:
- Serum-free adherence assays to test pre-B cell binding to fibronectin (FN).
- Co-culture experiments with stromal cell lines (M2-10B4) and pre-B cells, using anti-FN receptor antibodies.
- Analysis of cell surface molecules and mRNA expression for FN receptors (VLA).
Main Results:
- Freshly isolated and immortalized nontumorigenic pre-B cells adhere to FN via an RGD site, a function lost upon differentiation into B cells.
- Anti-FN receptor antibodies significantly reduced proliferation of nontumorigenic pre-B cells co-cultured with stromal cells.
- Tumorigenic, stromal-independent pre-B cell lines did not bind to FN, and anti-FN receptor antibodies had minimal effect on their proliferation.
- Alterations in FN receptor (VLA) expression, specifically increased alpha chains and decreased beta 1 chain in some cases, were observed in tumorigenic pre-B cells.
Conclusions:
- Pre-B cell attachment to fibronectin (FN) on stromal cells is a key mechanism for stromal-supported proliferation.
- Loss of FN binding due to altered FN receptor expression may contribute to the development of stromal-independent, autocrine leukemic pre-B cells.